Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice

Endocrinology (United States)

Volumn 156, Issue 2, 2015, Pages 411-418

  Cardinal, Pierre ^a   Bellocchio, Luigi ^b   Guzmán Quevedo, Omar ^b   André, Caroline ^a   Clark, Samantha ^a   Elie, Melissa ^b   Leste Lasserre, Thierry ^b   Gonzales, Delphine ^a   Cannich, Astrid ^a   Marsicano, Giovanni ^b   Cota, Daniela ^a  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; CORTICOSTERONE; CYTOCHROME C OXIDASE; GLUCOSE; INSULIN; MESSENGER RNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; SOMATOMEDIN C; UNCOUPLING PROTEIN 1; VESICULAR GLUTAMATE TRANSPORTER 2; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; SIM1 PROTEIN, MOUSE;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY TEMPERATURE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIMETRY; CHEMICAL SYMPATHECTOMY; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET INDUCED OBESITY; ENERGY BALANCE; ENERGY EXPENDITURE; FAT MASS; FEEDING BEHAVIOR; FOOD INTAKE; GENE; GENE DELETION; GENE INTERACTION; GLUCOSE METABOLISM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; LOCOMOTION; LOXP SITE; MALE; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY QUOTIENT; SIM1 GENE; THERMOGENESIS; THERMOREGULATION; WEIGHT GAIN; ANIMAL; ENERGY METABOLISM; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ENERGY METABOLISM; MALE; MICE, KNOCKOUT; NEURONS; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RECEPTOR, CANNABINOID, CB1; REPRESSOR PROTEINS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84921628040     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1437     Document Type: Article

References (34)

1. BermuDez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol. 2012;26:114-124
2. Cota D, Marsicano G, Tschp M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest. 2003;112:423-431
3. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubri P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord. 2004;28:640-648
4. Quarta C, Bellocchio L, Mancini G, et al. CB(1) signaling in forebrain and sympathetic neurons is a key Determinant of endocannabinoid actions on energy balance. Cell Metab. 2010;11:273-285
5. Cardinal P, Bellocchio L, Clark S, et al. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology. 2012;153:4136-4143
6. Horvath TL. The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci. 2005;8:561-565
7. Zheng H, Berthoud HR. Neural systems controlling the drive to eat: mind versus metabolism. Physiology (Bethesda). 2008;23:75-83
8. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci. 1983;6:269-324
9. Bamshad M, Song CK, Bartness TJ. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol. 1999;276:R1569-R1578
10. Geerling JC, Shin JW, Chimenti PC, Loewy AD. Paraventricular hypothalamic nucleus: axonal projections to the brainstem. J Comp Neurol. 2010;518:1460-1499
11. Biag J, Huang Y, Gou L, et al. Cyto-And chemoarchitecture of the hypothalamic paraventricular nucleus in the C57BL/6J male mouse: a study of immunostaining and multiple fluorescent tract tracing. J Comp Neurol. 2012;520:6-33
12. Hill MN, Tasker JG. Endocannabinoid signaling, glucocorticoidmediated negative feedback, and regulation of the hypothalamicpituitary-Adrenal axis. Neuroscience. 2012;204:5-16
13. Michaud JL, Rosenquist T, May NR, Fan CM. Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev. 1998;12:3264-3275
14. Michaud JL, Boucher F, Melnyk A, et al. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 2001;10:1465-1473
15. Kublaoui BM, HolDer JL Jr, Tolson KP, Gemelli T, Zinn AR. SIM1 overexpression partially rescues agouti yellow and diet-induced obesity by normalizing food intake. Endocrinology. 2006;147:4542-4549
16. Yang C, Gagnon D, Vachon P, Tremblay A, Levy E, Massie B, Michaud JL. ADenoviral-mediated modulation of Sim1 expression in the paraventricular nucleus affects food intake. J Neurosci. 2006; 26:7116-7120
17. Xi D, Gandhi N, Lai M, Kublaoui BM. Ablation of Sim1 neurons causes obesity through hyperphagia and reduced energy expenditure. PLoS One. 2012;7:e36453
18. Vong L, Ye C, Yang Z, Choi B, Chua S Jr, Lowell BB. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron. 2011;71:142-154
19. Xu Y, Wu Z, Sun H, et al. Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation. Cell Metab. 2013;18:860-870
20. Dubreucq S, Kambire S, Conforzi M, et al. Cannabinoid type 1 receptors located on single-minDed 1-expressing neurons control emotional behaviors. Neuroscience. 2012;204:230-244
21. Bellocchio L, Soria-Gmez E, Quarta C, et al. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockaDe. Proc Natl Acad Sci USA. 2013; 110:4786-4791
22. BinDer E, BermuDez-Silva FJ, Elie M, et al. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice. Obesity (Silver Spring). 2014;22:713-720
23. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Amsterdam, The Netherlands: Elsevier; 2008
24. Cota D, Steiner MA, Marsicano G, et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamicpituitary-Adrenal axis function. Endocrinology. 2007;148:1574-1581
25. Clapham JC. Central control of thermogenesis. Neuropharmacology. 2012;63:111-123
26. Nisoli E, Tonello C, Landi M, Carruba MO. Functional studies of the first selective 3-Adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol Pharmacol. 1996;49:7-14
27. Ootsuka Y, Kulasekara K, De Menezes RC, Blessing WW. SR59230A, a-3 adrenoceptor antagonist, inhibits ultradianbrown adipose tissue thermogenesis and interrupts associated episodic brain and body heating. Am J Physiol Regul Integr Comp Physiol. 2011;301:R987-R994
28. Robidoux J, Martin TL, Collins S.-Adrenergic receptors and regulation of energy expenditure: a family affair. Annu Rev Pharmacol Toxicol. 2004;44:297-323
29. Arendt RM, Greenblatt DJ, DeJong RH, Bonin JD, Abernethy DR. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol. Cardiology. 1984;71: 307-314
30. Finch L, Haeusler G, Thoenen H. A comparison of the effects of chemical sympathectomy by 6-hydroxydopamine in newborn and adult rats. Br J Pharmacol. 1973;47:249-260
31. Pertwee RG, Howlett AC, Abood ME, et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 2010;62: 588-631
32. Monge-Roffarello B, Labbe SM, Roy MC, et al. The PVH as a site of CB1-mediated stimulation of thermogenesis by MC4R agonism in male rats. Endocrinology. 2014;155:3448-3458
33. Lynch GS, Ryall JG. Role of-Adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev. 2008;88:729-767
34. Wijers SL, Schrauwen P, Saris WH, Van Marken Lichtenbelt WD. Humanskeletal muscle mitochondrial uncoupling is associated with cold induced adaptive thermogenesis. PLoS One. 2008;3:e1777.